Bone Density: Diagnosis and Management—What Is the True Burden of Disease?

Moderator:

Discussants:

  • Summary:

    Dr. Eric Gall from the University of Arizona Arthritis Center moderated the topic "Bone Density: Diagnosis and Management—What Is the True Burden of Disease?" with Drs. Jeffrey R. Lisse from the University of Arizona Arthritis Center, Michael Maricic from Catalina Point Rheumatology, and Michael McClung from Oregon Osteoporosis Center, Portland, OR.

    The discussion focused primarily on:

    1. Defining osteopenia and osteoporosis;
    2. the diagnosis of osteopenia and osteoporosis using dual-energy X-ray absorptiometry and the Fracture Risk Assessment Tool;
    3. the different categories of osteopenia and osteoporosis;
    4. the use of bone marker testing in deciding when to treat and in monitoring treatment;
    5. the comorbidities and conditions associated with low bone density;
    6. the modifiable and nonmodifiable risk factors for low bone density;
    7. the prevention and treatment of low bone density;
    8. the risks and benefits of hormone replacement therapy in preventing bone loss and fracture;
    9. the use of bisphosphonate therapy in treating low bone density; and
    10. the importance and means of monitoring treatment.

    Med Roundtable Gen Med Ed. 2014;1(4):302–311.

You are not authorized to access this content.

You are not authorized to access this content.
You are not authorized to access this content.
Please subscribe to use our print features or to download PDF files.